Evaluation of serum nitric oxide synthase levels in patients with coronary slow flow based on corrected TIMI frame

Jamal Shamsara1, Sepideh Elyasi2, Mostafa Dastani3

  • 1Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

Insights

This study found no significant correlation between nitric oxide synthase (NOS) serum levels and coronary slow flow phenomenon (CSFP) in patients. Further human studies are needed to confirm these findings regarding NOS isoforms and CSFP.

Area of Science:

  • Cardiology
  • Biochemistry
  • Vascular Biology

Background:

  • Coronary slow flow phenomenon (CSFP) is characterized by delayed distal vessel filling on angiography without significant epicardial coronary artery disease.
  • The endothelium plays a crucial role in cardiovascular homeostasis through vasoactive substance release, notably nitric oxide (NO).
  • Nitric oxide synthase (NOS) exists in three isoforms: eNOS, nNOS, and iNOS, each with distinct roles.

Purpose of the Study:

  • To investigate the role of nitric oxide synthase (NOS) in the development of coronary slow flow phenomenon (CSFP) in a human cohort.
  • To determine the correlation between serum NOS levels and the severity of CSFP, quantified by the corrected TIMI frame count (CTFC).

Main Methods:

  • 129 patients were categorized into five groups based on coronary angiography findings (presence/absence of CAD and CSFP).
  • Serum levels of total NOS were measured in all participants.
  • Coronary flow in CSFP patients was assessed using the corrected TIMI frame count (CTFC).

Main Results:

  • No significant correlation was observed between total serum NOS levels and the mean CTFC in patients with CSFP.
  • The lack of correlation may be attributed to a potential imbalance in NOS isoforms, such as increased iNOS and decreased eNOS concentrations.

Conclusions:

  • The study did not find a direct correlation between overall serum NOS levels and the severity of CSFP.
  • Further research involving human subjects is recommended to elucidate the specific roles of different NOS isoforms in CSFP pathogenesis.
Abstract